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Abstract
Introduction: We aimed to gather knowledge on the cardiac autonomic modulation in patients with fibromyalgia
(FM) in response to exercise and to investigate whether this population suffers from chronotropic incompetence
(CI).
Methods: Fourteen women with FM (age: 46 ± 3 years; body mass index (BMI): 26.6 ± 1.4 kg/m
2) and 14 gender-,
BMI- (25.4 ± 1.3 kg/m
2), and age-matched (age: 41 ± 4 years) healthy individuals (CTRL) took part in this cross-
sectional study. A treadmill cardiorespiratory test was performed and heart-rate (HR) response during exercise was
evaluated by the chronotropic reserve. HR recovery (deltaHRR) was defined as the difference between HR at peak
exercise and at both first (deltaHRR1) and second (deltaHRR2) minutes after the exercise test.
Results: FM patients presented lower maximal oxygen consumption (VO2 max) when compared with healthy
subjects (22 ± 1 versus CTRL: 32 ± 2 mL/kg/minute, respectively; P < 0.001). Additionally, FM patients presented
lower chronotropic reserve (72.5 ± 5 versus CTRL: 106.1 ± 6, P < 0.001), deltaHRR1 (24.5 ± 3 versus CTRL: 32.6 ± 2, P
= 0.059) and deltaHRR2 (34.3 ± 4 versus CTRL: 50.8 ± 3, P = 0.002) than their healthy peers. The prevalence of CI
was 57.1% among patients with FM.
Conclusions: Patients with FM who undertook a graded exercise test may present CI and delayed HR recovery,
both being indicative of cardiac autonomic impairment and higher risk of cardiovascular events and mortality.
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Introduction
Fibromyalgia (FM) is a chronic syndrome characterized
by widespread pain and discomfort. In general, FM is
accompanied by other symptoms such as fatigue, sleep
disorders, reduced muscular strength and endurance,
parasthesis, irritable bowel and joint stiffness [1]. Over
the last two decades, the understanding regarding FM
physiopathology has substantially advanced, with a
growing body of evidence suggesting that autonomic
nervous system dysfunction (also called dysautonomia)
plays a role in this disease [2-4].
In this regard, Furlan et al. [ 5 ]s h o w e dt h a tw o m e n
with FM have exacerbated sympathetic activity at rest.
Furthermore, FM women undertaking a tilt test dis-
played an inability to increase sympathetic discharge
and decrease vagal activity. Accordingly, dysautonomia
has also been noticed in response to standing and cold
exposure [6], both well-known autonomic function
stressors.
Importantly, autonomic nervous system dysfunction
has been associated with higher cardiovascular risk in
several populations [7,8]. In this regard, heart rate (HR)
response to a graded exercise test has been largely used
for assessing risks and prognoses in patients with overt
or subclinical cardiovascular diseases [9,10]. For exam-
ple, an attenuated HR response to exercise (that is,
chronotropic incompetence (CI))-which results from the
combination of parasympathetic withdrawn and sympa-
thetic activation-has been considered a strong and inde-
pendent predictor of mortality and coronary heart
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standard cardiovascular risk factors and ST-segment
changes with exercise [9,10]. Kingsley et al. [11] evalu-
ated for the first time autonomic modulation in women
with FM after an acute bout of resistance exercise. The
authors contended that patients had greater parasympa-
thetic and lower sympathetic modulation than healthy
controls. However, the authors did not evaluate auto-
nomic control during exercise, precluding a more defini-
tive conclusion about their findings [11]. In this respect,
Van Denderen et al. 1992 observed attenuated (nor)epi-
nephrine concentrations during a graded exercise until
exhaustion in FM patients versus healthy controls, sug-
gesting a disturbance in autonomic control.
Thus, we aimed to gather knowledge on the cardiac
autonomic modulation in FM patients in response to
exercise and to investigate whether this population suf-
fers from CI.
Materials and methods
Study design and patients
This was a cross-sectional case-control study. The sam-
ple consisted of 14 women with primary FM (age: 46 ±
3 years; BMI: 26.6 ± 1.4 kg/m
2) and 14 gender-, BMI-
(25.4 ± 1.3 kg/m
2), and age-matched (41 ± 4 years)
healthy individuals (CTRL). All patients fulfilled the
revised American College of Rheumatology preliminary
diagnostic criteria for FM [12].
Exclusion criteria were: i) cardiovascular involvement
(for example, arrhythmias, arterial hypertension, heart
failure, conduction disturbances, myocarditis and peri-
carditis); ii) tobacco usage; iii) use of chronotropic and
antihypertensive drugs; iii) other chronic diseases (for
example, systemic lupus erythematosus, rheumatoid
arthritis, diabetes mellitus, dyslipidemia and chronic kid-
ney disease). At entry, patients were taking analgesics
(50.0%), anti-depressive drugs (35.7%), muscle relaxants
(35.7%), nonsteroidal anti-inflammatory drugs (21.4%),
and anticonvulsants (7.4%) in stable doses for at least
three months. Control subjects were not taking any
medication. Both patients and controls were not
engaged in regular physical activity programs for the
past six months prior to the study.
The study was approved by the Local Ethical Commit-
tee and all of the subjects signed the written informed
consent.
Cardiorespiratory exercise testing
A modified Balke treadmill (Centurion, model 200,
Micromed, Brasília, Brazil) maximal exercise test [13]
was used to assess the cardiac autonomic modulation
in patients with FM in response to exercise. Oxygen
consumption (VO2) and carbon dioxide output were
obtained through breath-by-breath sampling and
expressed as a 30-s average using an indirect calorime-
try system (Cortex-model Metalyzer III B, Leipzig,
Germany). HR was continuously recorded at rest, dur-
ing exercise and at recovery, using a 12-lead electro-
cardiogram (Ergo PC Elite, InC. Micromed, Brasília,
Brazil). The recovery period was set at two minutes
using the initial workload (1.9 mph). Maximal oxygen
consumption (VO2 max), ventilatory anaerobic thresh-
o l d( V A T )a n dr e s p i r a t o r ycompensation point (RCP)
were determined according to previously described cri-
teria [14].
HR response during exercise and recovery
HR response during exercise was evaluated by the
chronotropic reserve, as follows: (chronotropic reserve =
(peak HR-resting HR/220-age-resting HR) × 100) [15].
CI was determined when subjects failed to achieve <
80% of the chronotropic reserve, despite reaching a peak
exercise respiratory exchange ratio (RER) > 1.05 (which
suggests adequate effort) [15]. HR recovery (deltaHRR)
was defined as the difference between HR at peak exer-
cise and at both first (deltaHRR1) and second (del-
taHRR2) minutes after exercise.
Statistical analysis
Data are presented as mean ± S.E.M. Unpaired Student
t-tests were used to assess differences between groups
for all of the dependent variables. Absolute change was
used to calculate the difference between the HR at peak
exercise and at the first and second minutes after the
exercise test. Significance level was previously set at P <
0.05.
Results
All subjects achieved RER > 1.05 and volitional exhaus-
tion. Significant differences were found in VO2 max
(FM: 22 ± 1 vs. CTRL: 32 ± 2 mL/kg/min, P < 0.01),
peak HR (FM: 148 ± 5 vs. CTRL: 177 ± 3 bpm, P <
0.001), HR at RCP (FM: 133 ± 4 vs.C T R L :1 7 7±5
bpm, P < 0.001).
Chronotropic reserve was significantly lower for the
patients with FM when compared with CTRL (72.5 ± 5
vs. 106.1 ± 6, respectively; P < 0.001) (Figure 1). Eight of
the 14 patients with FM (57.1%) presented CI whereas
none of the healthy subjects presented it. deltaHRR1
(FM: 24.5 ± 3 vs.C T R L :3 2 . 6±2b p m ;P = 0.059) and
deltaHRR2 (FM: 34.3 ± 4 vs. CTRL: 50.8 ± 3; P = 0.002)
were also lower in FM versus CTRL (Figure 2, panels A
and B, respectively).
Discussion
This study indicates that patients with FM present
abnormal HR response during and after exercise. In
addition, we have identified that 57.1% of the patients
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Page 2 of 5Figure 1 Chronotropic reserve during exercise in patients with fibromyalgia (FM) and healthy controls (CTRL). Data are expressed as
mean and individual data. * P < 0.001 vs. controls.
Figure 2 Changes in heart-rate recovery at the first (deltaHRR1) and second (deltaHRR2) minute of recovery. Horizontal bars represent
the means. * indicates P = 0.059 and P = 0.002 when compared with CTRL at deltaHRR1 and delta HRR2, respectively.
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and cardiac death [7,8].
CI has been recognized as a predictor of outcome in
several cohorts that have included tens of thousands of
patients [10,16]. For instance, Sandvik et al. [10]
observed that the HR increase during exercise was nega-
tively associated with survival and that a reduction in
t h eH Ri n c r e a s ew a sas t r o n gp r e d i c t o ro fm o r t a l i t y
from cardiovascular disease in a cohort of apparently
healthy men. We observed a similar abnormal chrono-
tropic response, suggesting that FM patients may also
have a higher risk of mortality when compared with
their healthy matched controls.
The mechanisms underlying CI during exercise still
remain elusive. However, the most likely explanation for
abnormal HR response involves abnormalities in auto-
nomic nervous system modulation [17]. Several studies
using power spectrum analysis of HR variability with
different stressors (for example, tilt table test and 24 h
electrocardiogram registration) have showed increased
sympathetic and decreased parasympathetic tones in FM
patients [2-4]. Interestingly, this autonomic dysfunction
appears to be characterized by sustained sympathetic
hyperactivity at rest, and hyporeactivity to stress [1]. In
this context, the blunted HR response during exercise
seen in FM patients may be related to the desensitiza-
tion of cardiac b1 receptors through a heightened sym-
pathetic activity similart oh e a r tf a i l u r e[ 1 7 ] .
Longitudinal studies are necessary to test the predictive
power of CI as a non-invasive marker of risk in patients
with FM.
In addition to the sympathetic hypoactivity observed
during maximal exercise, cardiac autonomic impairment
was noted following exercise, as suggested by a delayed
deltaHRR recovery, which is initially affected by para-
sympathetic reactivation followed by sympathetic with-
drawal. Altogether, these findings suggest that
dysautonomia may play a role in FM. However, addi-
tional studies using more direct measurements of auto-
nomic nervous system (for example, microneurography)
may provide further insights on dysautonomia in FM.
Importantly, autonomic dysfunction has been asso-
ciated with a variety of symptoms in FM, including
sleep disorders, chronic pain, allodynia, anxiety, pseudo-
Raynaud’s phenomenon, sicca syndrome and intestinal
irritability [18]. Thus, strategies aimed to attenuate dys-
autonomia may be considered therapeutically promising
in FM. In this regard, Figueroa et al. [ 2 ]s h o w e dt h a ta
16-week resistance training program led to improve-
ments in resting vagal modulation and pain perception
in women with FM. Additionally, the same group
demonstrated that aerobic exercise training may
improve post-exercise autonomic modulation in obese
and type 2 diabetic patients [19]. Long-term studies
should explore the therapeutic role of different types of
exercise training (for example, low- or high-intensity,
resistance, endurance or combined exercise programs)
in modulating autonomic nervous system (for example,
delayed HR recovery) in FM. Whether or not exercise-
induced autonomic modulation may ameliorate CI in
FM patients is also unclear.
Even though we have excluded all subjects taking
drugs which affect chronotropic response to exercise
(for example, beta-blockers), it is important to note that
our patients were under a variety of medications (for
example, antidepressant drugs), which may somehow
affect the autonomic system [20]. Nonetheless, we
extensively reviewed the literature and found no evi-
dence of an influence of such drugs on chronotropic
reserve or HR recovery. Accordingly, post-hoc sub-group
analyses revealed that patients not taking antidepres-
sants also had delayed HR recovery when compared
with paired controls (deltaHRR1 = -13 bpm; P =0 . 0 2
and deltaHRR1 = -20 bpm; P = 0.002). Moreover, five of
nine patients (55.5%) not using antidepressant drugs
presented CI. This prevalence was similar to that
observed in subjects altogether (57.1%), suggesting that
these drugs played a minor (if any) role in the current
findings. Further studies assessing patients free of medi-
cation may be needed to fully clarify this issue.
Considering that both RER and HR during exercise
a r ed e p e n d e n to nt h ev o l i t i o n a le f f o r to ft h ep e r s o n
exercising, one may speculate that a submaximal effort
m a ye x p l a i nt h el o wH Rr e s p o n s e si n5 7 %o ft h eF M
patients tested. However, all of the patients reported
volitional exhaustion at the end of the test. This, along
with the fact that a RER greater than 1.05 was achieved
in all tests, allows us to believe that CI may actually
have accounted for low HR responses seen in this study.
Conclusions
Patients with FM presented an abnormal HR response
to exercise, suggesting cardiac autonomic impairment
and higher risk of cardiac events and mortality.
Key messages
￿ Patients with fibromyalgia present cardiac auto-
nomic impairment in response to exercise.
￿ Chronotropic incompetence and delayed heart-rate
recovery may predispose fibromyalgic patients to a
higher mortality risk.
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